Marizyme Inc (MRZM) Stock Price & News

All values in USD	Sep 2012	Dec 2012	Mar 2013	Sep 2024
Revenue	-	-	-	-
Cost of goods sold	-	-	-	-
Cost of revenue	-	-	-	-
Research and development expenses	-	-	-	344.14K
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	-	-	-	881.32K
Operating expense	-	-	-	1.36M
Total operating expenses	-	-	-	1.36M
Operating income	-	-	-	-1.36M
Other non operating income	-	-	-	-4.31K
EBT including unusual items	-	-	-	-1.96M
EBT excluding unusual items	-	-	-	-2.46M
Income tax expense	-	-	-	-
Effective tax rate	-	-	-	-
Other operating expenses	-	-	-	-
Net income	-	-	-	-1.96M
Net profit margin	-	-	-	-
Earnings per share	-	-	-	-
Interest and investment income	-	-	-	-
Interest expense	-	-	-	-1.10M
Net interest expenses	-	-	-	-1.10M
Depreciation and amortization charges	-	-	-	108.78K
EBITDA	-	-	-	-1.25M
Gain or loss from assets sale	-	-	-	-

Finance